or Try an Advanced Search...

    Technical Analysis for NVCT - Nuvectis Pharma, Inc.

    Grade Last Price % Change Price Change
    D 6.18 -2.37% -0.15
    NVCT closed down 2.37 percent on Monday, July 1, 2024, on 73 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NVCT trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish -2.37%
    50 DMA Resistance Bearish -2.37%
    MACD Bearish Centerline Cross Bearish -2.37%
    Pocket Pivot Bullish Swing Setup -2.37%
    Volume Surge Other -2.37%
    Older End-of-Day Signals for NVCT ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance about 10 hours ago
    20 DMA Resistance about 10 hours ago
    Up 5% about 10 hours ago
    Up 3% about 10 hours ago
    Up 2% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NVCT Chart by TradingView
    Basic chart:

    Profile

    Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of targeted small molecule therapeutics for the treatment of cancer. The company develops NXP800, an oral small molecule inhibitor of the Heat Shock Factor 1 pathway, a signaling pathway in the initiation and progression of various cancers; and NXP900 program, an oral small molecule designed to inhibit the SRC and YES1 kinases. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Life Sciences Biology Treatment Of Cancer Tyrosine Kinase Oncogenes Cancer Research Small Molecule Kinase Proto Oncogene Tyrosine Protein Kinase Src

    Is NVCT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 24 Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
    May 16 Nuvectis Pharma: An Interesting Early Pipeline Does Not Justify A Buy
    May 16 Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
    May 8 Nuvectis Pharma Inc Reports Q1 2024 Financial Outcomes
    May 7 Nuvectis Pharma Q1 EPS of -$0.25
    May 7 Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
    Apr 17 Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans?
    Apr 8 Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
    Apr 2 5 Healthcare Stocks to Buy for 2024
    Mar 21 Insider Buys Additional US$51k In Nuvectis Pharma Stock
    See more NVCT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 16.4
    52 Week Low 5.85
    Average Volume 108,427
    200-Day Moving Average 8.41
    50-Day Moving Average 6.61
    20-Day Moving Average 6.61
    10-Day Moving Average 6.68
    Average True Range 0.56
    RSI (14) 42.53
    ADX 13.14
    +DI 13.56
    -DI 20.47
    Chandelier Exit (Long, 3 ATRs) 5.74
    Chandelier Exit (Short, 3 ATRs) 7.63
    Upper Bollinger Bands 7.20
    Lower Bollinger Band 6.02
    Percent B (%b) 0.14
    BandWidth 17.92
    MACD Line -0.05
    MACD Signal Line 0.00
    MACD Histogram -0.0493
    Fundamentals Value
    Market Cap 107.08 Million
    Num Shares 17.3 Million
    EPS -1.50
    Price-to-Earnings (P/E) Ratio -4.12
    Price-to-Sales 0.00
    Price-to-Book 7.15
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 7.02
    Resistance 3 (R3) 7.09 6.88 6.88
    Resistance 2 (R2) 6.88 6.67 6.85 6.83
    Resistance 1 (R1) 6.53 6.53 6.43 6.46 6.79
    Pivot Point 6.32 6.32 6.27 6.29 6.32
    Support 1 (S1) 5.97 6.11 5.87 5.90 5.57
    Support 2 (S2) 5.76 5.97 5.73 5.53
    Support 3 (S3) 5.41 5.76 5.48
    Support 4 (S4) 5.34